Novel protein tyrosine phosphatase (PTP) inhibitor compounds synthesized from phosphonodifluoromethyl phenylalanine (F2Pmp) are provided. Use of these compounds for inhibiting a PTP enzyme (such as PTP-MEG2), as well as treating a disease, disorder, or condition associated with inappropriate activity of a PTP (such as type 2 diabetes), is also provided.
提供了从
磷酸二
氟甲基苯丙
氨酸(F2Pmp)合成的新型蛋白
酪氨酸磷酸酶(
PTP)
抑制剂化合物。还提供了使用这些化合物来抑制
PTP酶(如
PTP-
MEG2),以及治疗与
PTP不当活性相关的疾病、紊乱或病况(如2型糖尿病)的方法。